FDA's New Digital Health Unit and Guidance for MHealth and Telemedicine Companies
June 26, 2017
In connection with its efforts to support technological innovation and advancement of digital health, the U.S. Food and Drug Administration (FDA) has announced two new resources: 1) the creation of a new centralized Digital Health Unit within its Center for Devices and Radiological Health (CDRH) and 2) the issuance of draft guidance on Software as a Medical Device (SaMD): Clinical Evaluation released last fall.
SaMD is an area of digital health where FDA guidance has been rapidly evolving.
To continue reading this article written by Nathaniel Lacktman, Jason Drori and Taylor Whitten, click here.
SaMD is an area of digital health where FDA guidance has been rapidly evolving.
To continue reading this article written by Nathaniel Lacktman, Jason Drori and Taylor Whitten, click here.
Author(s)
Related Insights
July 9, 2025
Powered by Foley
Energy Industry Disputes
Whether we like it or not, there’s always a chance a dispute will arise during the lifespan of an energy project, which may only accelerate following changes to federal energy tax credits that could significantly upend parties’ commercial assumptions.
July 8, 2025
Energy Current
What’s the Future for Renewable Energy Tax Credits in Congress?
The One Big Beautiful Bill Act (OBBB) has a significant impact on the renewable energy sector, particularly with changes in the phase-out…
July 8, 2025
Energy Current
Executive Order on PTC and ITC Beginning of Construction
President Trump yesterday issued an executive order, “Ending Market Distorting Subsidies for Unreliable, Foreign Controlled Energy…